Integra LifeSciences (IART)
(Real Time Quote from BATS)
$17.32 USD
-0.15 (-0.86%)
Updated Sep 20, 2024 12:09 PM ET
5-Strong Sell of 5 5
A Value D Growth A Momentum C VGM
Integra LifeSciences (IART) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$27.70 | $40.00 | $20.00 | 58.56% |
Price Target
Based on short-term price targets offered by 10 analysts, the average price target for Integra LifeSciences comes to $27.70. The forecasts range from a low of $20.00 to a high of $40.00. The average price target represents an increase of 58.56% from the last closing price of $17.47.
Analyst Price Targets (10)
Broker Rating
Integra LifeSciences currently has an average brokerage recommendation (ABR) of 3.22 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 3.22 a month ago based on 12 recommendations.
Of the 12 recommendations deriving the current ABR, two are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 16.67% and 8.33% of all recommendations. A month ago, Strong Buy made up 16.67%, while Buy represented 8.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 4 | 6 | 6 |
Sell | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 3 | 3 | 3 | 1 | 1 |
ABR | 3.22 | 3.22 | 3.22 | 2.89 | 2.89 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/30/2024 | BTIG | Ryan Zimmerman | Hold | Strong Sell |
7/30/2024 | Not Identified | Not Identified | Hold | Strong Sell |
7/30/2024 | JMP Securities | David L Turkaly | Strong Buy | Strong Buy |
7/15/2024 | Not Identified | Not Identified | Hold | Hold |
5/7/2024 | Truist Securities | Richard Newitter | Hold | Hold |
5/7/2024 | Wells Fargo Securities | Vikramjeet S Chopra | Strong Buy | Hold |
5/6/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/6/2024 | Not Identified | Not Identified | Strong Buy | Hold |
4/25/2024 | C.L. King & Associates | Kristen M Stewart | Moderate Buy | Moderate Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.22 |
ABR (Last week) | 3.22 |
# of Recs in ABR | 12 |
Average Target Price | $27.70 |
LT Growth Rate | 12.00% |
Industry | Medical - Instruments |
Industry Rank by ABR | 72 of 253 |
Current Quarter EPS Est: | 0.39 |
IART FAQs
Integra LifeSciences Holdings Corporation (IART) currently has an average brokerage recommendation (ABR) of 3.22 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms.
The average price target for Integra LifeSciences Holdings Corporation (IART) is $27.70. The current on short-term price targets is based on 8 reports.
The forecasts for Integra LifeSciences Holdings Corporation (IART) range from a low of $20 to a high of $40. The average price target represents a increase of $58.56 from the last closing price of $17.47.
The current UPSIDE for Integra LifeSciences Holdings Corporation (IART) is 58.56%
Based on short-term price targets offered by 10 analysts, the average price target for Integra LifeSciences comes to $27.70. The forecasts range from a low of $20.00 to a high of $40.00. The average price target represents an increase of 58.56% from the last closing price of $17.47.